DXB 8.89% 49.0¢ dimerix limited

Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-24

  1. 805 Posts.
    lightbulb Created with Sketch. 143
    It might not be as fancy, but this is how interested AZ is in kidney disease, and this is just one big pharma company...
    Someone might want some propagermanium to get an edge...

    https://hotcopper.com.au/data/attachments/3255/3255525-fda26461314bdcb3549e1e0e3d070428.jpg

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
49.0¢
Change
0.040(8.89%)
Mkt cap ! $269.6M
Open High Low Value Volume
46.0¢ 50.5¢ 46.0¢ $2.255M 4.621M

Buyers (Bids)

No. Vol. Price($)
1 100000 49.0¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 21052 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.